RCA in the commercial property press:


Morgan Stanley Takes $251 Million Charge for Crescent


Wednesday, October 21, 2009
Source: Bloomberg


Bloomberg reports: Morgan Stanley recorded a $251 million impairment charge on its Crescent real estate unit, another sign the $6.5 billion purchase made in 2007 is facing economic challenges.

Morgan Stanley is in talks with Barclays Capital to avert default on a $2 billion loan used to buy Crescent Real Estate Equities, according to people with knowledge of the situation. Morgan Stanley bought Crescent as the U.S. property market peaked and has since sold some of the assets to pay debt. The purchase gave the investment bank 54 office buildings in cities including Dallas, Houston, Denver, Miami and Las Vegas.

"They paid top dollar for those assets when they bought out Crescent," said Peter Slatin, editorial director at New York-based Real Capital Analytics, which tracks commercial real estate pricing worldwide. "They paid a pretty penny."

Commercial property values in the U.S. have plunged since 2007 as employers shed jobs and the recession reduced demand for offices, retail space and rental apartments. The Moody’s/REAL Commercial Property Price Indices fell 3 percent in August from July, bringing the decline to almost 41 percent since October 2007.


View the full article on Bloomberg: Morgan Stanley Takes $251 Million Charge for Crescent


Articles related to this topic:

Bullet Point Moody's Property Index Resumes 'Steep' Fall in July
Bullet Point Lenders get back nearly 60% on foreclosures
Bullet Point Price Declines Start to Level Off

Posted by: Matthew Stone

<< PrevNext >>
 

Most Active

 MarketVol.(bil)Cap rate
1 NYC Metro$42.26.16%
2 London Me...$33.25.71%
3 Tokyo$27.85.63%
4 Shanghai$26.25.22%
5 Singapore$21.95.07%
6 Beijing$21.0 
7 DC Metro$19.76.31%
8 Hong Kong$19.33.31%
9 Paris$18.16.24%
10 LA Metro$17.26.23%
Based on live data; deals valued at $10 mil. or greater reported in contract or closed in past 12 months
 
Contact

Real Capital Analytics, Inc.
+1 212-387-7103


Trouble Logging In?